SAN FRANCISCO, Jan. 10 (GenomeWeb News) - Affymetrix will open a clinical lab business next year with an eye toward growing its molecular diagnostics business, CEO Stephen Fodor said yesterday at the JPMorgan Healthcare Conference, held here this week.
Affymetrix Clinical Laboratories will be based in
In addition to the clinical lab business, Fodor said Affymetrix has broken ground on a new microarray and reagent-manufacturing facility in
The firm had some problems with manufacturing capacity during 2005, which partially contributed to a shortfall in fourth-quarter and full-year revenue. In response to those difficulties, Affymetrix expanded its capacity 30 percent during the fourth quarter of 2005, and company officials said the firm would expand manufacturing capacity an additional 30 percent during the first quarter of 2006.
Affymetrix officials also noted at the conference that the firm is leasing a manufacturing facility in